S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › ACCON › Research report
← ACCON page
XStocksXray
Market X-Ray report · 20 October 2026

Acconeer AB (ACCON)

Stockholm Exchange · Sweden · prices in SEK · close of 20 Oct 2026

Key indicators

Last closeSEK 11.00
52-week range4.92 – 26.90
Return, 1 month / 3 months−7.6% / −31.3%
Return, 1 year / 3 years+116.5% / −20.1%
TrendBelow its 200-day average
RSI (14)31
Volatility (1 year)87.4%
Worst drawdown (1 year)-56.3%
Average daily value traded2.21M SEK
Dividend yield–

Market X-Ray price-based

41/ 100 · High confidence · ahead of 34% of stocks on this exchange
Trend30
Momentum50
Stability (higher is calmer)25
Liquidity68
Income–

Five-year price chart navy: price · brown: 200-day average

0.3319.1137.8956.6775.452021-102023-012024-042025-072026-10

About the company

Acconeer is a Swedish technology company based in Lund that develops small radar sensors and the software that goes with them. Its sensors use pulsed coherent radar to detect presence, movement and distance, and they are supplied to manufacturers and developers who build them into consumer electronics, industrial equipment and other products. The company provides sensor modules, evaluation kits and supporting software so customers can integrate the technology into their own designs.

The shares are listed on the Stockholm Exchange in Sweden under the code ACCON, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Acconeer AB (ACCON) trades on the Stockholm Exchange in Sweden. It last closed at SEK 11.00 on 20 October 2026.

Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 604 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 116.5% and over the last three months it fell 31.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Acconeer AB (ACCON)

The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange

Lens and metricValueScoreReading
Trend30 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-21.7%
From 52-week high-55.8%
Momentum50 · FairTypical recent returns for this exchange.
3-month return-31.3%
6-month return-11.0%
12-month return, skipping the last month134.3%
Stability (higher is calmer)25 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)87.4%
Worst drawdown, 1 year (smaller is calmer)-56.3%
Liquidity68 · FairModerate trading activity.
Average daily value traded2.21M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−3.8%
1 month−7.6%
3 months−31.3%
6 months−11.0%
1 year+116.5%
3 years−20.1%
5 years−78.6%

Signals

50-day / 200-day average13.66 / 14.04
Golden / death cross (60 days)Death, 3 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.63

Technical summary

DailyStrongly bearish1 bullish · 3 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyNeutral3 bullish · 1 neutral · 4 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026